Spectrum Pharmaceuticals to Participate in H.C. Wainwright Global Investment Conference

On May 17, 2022 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, reported that management will participate in the upcoming H.C. Wainwright Global Investment Conference, to be held virtually and in Miami Beach from May 23-26, 2022 (Press release, Spectrum Pharmaceuticals, MAY 17, 2022, View Source [SID1234614744]). A presentation will be available on the Investor Relations section of the company’s website at View Source beginning on May 24, 2022 at 7:00 a.m. ET / 4:00 a.m. PT.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!